Previous Page  18 / 22 Next Page
Information
Show Menu
Previous Page 18 / 22 Next Page
Page Background

Endocrinology 2018

Journal of Clinical and Molecular Endocrinology

ISSN: 2572-5432

Page 57

August 09-10, 2018

Madrid, Spain

11

th

International Conference on

Endocrinology and

Diabetology

Background & Aim:

Genital anomalies including disorders of

sexual development (DSDs) are prevalent in all societies. There is

no study on DSDs in Ghana. We aimed to describe characteristics

of abnormal genitalia and prevalence of DSDs in neonates

delivered at Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Methods:

Trained research assistants performed systematic

genital examination in consecutive neonates over one year.

All neonates with suspected abnormal genitalia were further

examined by pediatric endocrinologists. Informed consent was

obtained for all participants.

Results:

A total of 10337 neonates (including 389 stillbirths)

were delivered. We examined 9255 neonates (93% of all live

births) within 72 hours of life. Normal genitalia were identified

in 47.93% females and 51.86% males. Nineteen neonates

(0.21%) had disorders of sexual disorders (DSDs). Seven had

ambiguous genitalia (four with clitoromegaly, presence of uterus

on ultrasound and elevated 17-hydoxyprogesterone, suggesting

CAH (Congenital adrenal hyperplasia). The remaining three had

microphallus, gonads in bifid scrotum or in the inguinal region,

suggesting male DSDs. The twelve other neonates had isolated

micropenis (n=5) and isolated hypospadias (n=7) and were

considered as males.

Conclusions:

DSDs including CAH is not uncommon in Ghana and

proper access to diagnostic tools and medicines is important.

Recommendation:

All babies in low income countries should

have genital examination at birth so as to identify DSDs and subtle

anomalies of genitalia at birth.

ekameyaw@yahoo.com

Prevalence of disorders of sexual development in neonates in

Ghana

Emmanuel Ameyaw

Kwame Nkrumah University of Science and Technology, Ghana

J Clin Mol Endocrinol 2018, Volume 3

DOI: 10.21767/2572-5432-C2-006